Obesity Medicine Association

Moving Your Compounded Semaglutide Treatment This is a common situation right now given FDA enforcement actions. Here are your best options: Branded GLP-1 Medications (Most Reliable) Novo Nordisk's Ozempic/Wegovy - The original semaglutide; work with your doctor or an endocrinologist to get a prescription Eli Lilly's Zepbound/Mounjaro (tirzepatide) - Many find it equally or more effective Telehealth Platforms Hims & Hers - Offers branded semaglutide options and has adapted to the compound restrictions Ro (Body) - Connects you with licensed providers and branded medications Calibrate - Focuses on metabolic health with GLP-1 prescriptions Found - Telehealth with obesity medicine specialists Direct Healthcare Options Your primary care doctor - Can prescribe Wegovy/Ozempic directly Obesity medicine specialists - Search via the Obesity Medicine Association directory Practical Tips Check insurance coverage first - Wegovy is increasingly covered Novo Nordisk's savings card can reduce costs significantly Ask about samples from your doctor's office Would you like more detail on cost, insurance navigation, or any specific platform?

Mentioned in position 5 of 5

Short answer — you’ll need a consultation with a licensed prescriber (primary care, endocrinologist, or obesity-medicine clinician). Many telemedicine services now evaluate patients for prescription weight‑loss medications like Zepbound and can arrange treatment, monitoring, and prior authorization if needed. Step‑by‑step Confirm you’re likely eligible. Zepbound (tirzepatide for weight management) is generally prescribed for adults with BMI ≥30 kg/m2 or BMI ≥27 with at least one weight‑related condition (eg, hypertension, type 2 diabetes, sleep apnea). A prescriber will check medical history and current medications and screen for contraindications (see next section). Choose a telemedicine route: Use your own primary‑care doctor or endocrinologist via their telehealth visit (best if you have complex medical issues). Use a telehealth clinic that offers anti‑obesity meds. Common services that offer weight‑loss medication consults include: Hims & Hers, Ro (Roman), PlushCare, Lemonaid Health, and Calibrate. These services arrange the consult, prescribe if appropriate, and often help with follow‑up. Look for an obesity‑medicine specialist via the Obesity Medicine Association provider directory or local weight‑management clinics that offer virtual visits. Book a visit and gather records. Before the appointment, have your recent weight/height (to calculate BMI), a list of medications, past medical history (esp. diabetes, pancreatitis, thyroid cancer, pregnancy status), and any recent labs (A1c, basic metabolic panel, liver tests) ready. The virtual visit. The clinician will assess eligibility, discuss risks/benefits, review alternatives, and — if appropriate — write a prescription or start a prior authorization with your insurer. They’ll also outline monitoring (lab checks, follow‑up visits). Fill the prescription. Many clinics can send the prescription to a local pharmacy or arrange shipment through a specialty pharmacy. Expect prior authorization delays with insurers and potentially high out‑of‑pocket costs; the provider’s staff usually helps with appeals, copay assistance, or manufacturer programs. Important safety/coverage points Contraindications/precautions: pregnancy or planned pregnancy, personal/family history of medullary thyroid carcinoma or MEN2, history of pancreatitis, and some severe GI disorders. If you’re on insulin or sulfonylureas, doses may need adjustment. Insurance: Many insurers require prior authorization and may deny coverage for newer agents. Expect phone calls and documentation. Check your plan and pharmacy benefits. Cost: Without coverage, tirzepatide can be expensive. Ask the telehealth clinic about manufacturer patient‑support programs, coupons, or pharmacy discount services (GoodRx, single‑use savings cards). Novo Nordisk also offers patient support programs — ask your provider or the manufacturer for details. Monitoring: Expect periodic follow‑ups, dose titration, and some labs (eg, A1c if diabetic, kidney function, and thyroid symptoms monitoring). If you want, I can: Help find telehealth providers that prescribe Zepbound in your state, Draft a checklist to bring to your telehealth visit, Or check likely insurance coverage if you tell me your insurer and plan type.

Mentioned in position 6 of 8

Short answer: Maybe — it depends on your current BMI, medical history, and whether you have weight‑related conditions. What doctors usually use For adults without diabetes, FDA approvals and guideline-based prescribing for GLP‑1s used for chronic weight management (e.g., Wegovy, Saxenda) generally follow one of: BMI ≥ 30 kg/m2 (obesity), or BMI ≥ 27 kg/m2 plus at least one weight‑related comorbidity (high blood pressure, high cholesterol, obstructive sleep apnea, or type 2 diabetes). If you have type 2 diabetes, GLP‑1s such as Ozempic or Mounjaro are commonly prescribed for blood‑sugar control and often help with weight loss; prescribing is guided primarily by diabetes care rather than BMI alone. Some clinicians do prescribe off‑label for lower BMIs, but that’s less common and often not covered by insurance. How to check quickly Calculate BMI = weight (lb) × 703 ÷ height (in)^2 (or use any online BMI calculator). Examples: 5'4" (64 in): BMI 30 ≈ 175 lb; BMI 27 ≈ 157 lb. 5'6" (66 in): BMI 30 ≈ 186 lb; BMI 27 ≈ 167 lb. If your current BMI meets the thresholds above, you’re likely to be considered a candidate; if not, you probably won’t meet standard criteria unless you have a qualifying comorbidity or diabetes. Medications to know by name Wegovy (semaglutide) — FDA‑approved for chronic weight management. Saxenda (liraglutide) — FDA‑approved for weight management. Ozempic (semaglutide) and Mounjaro (tirzepatide) — approved for type 2 diabetes; both frequently produce weight loss and are sometimes used off‑label for obesity treatment (tirzepatide shows strong weight‑loss results in studies). Note: approvals, dosing, and insurance coverage differ between these products. Safety, coverage, and cost Side effects: nausea, vomiting, constipation, risk of pancreatitis, gallbladder problems, and others. Not appropriate in pregnancy and contraindicated with personal/family history of medullary thyroid carcinoma or MEN2. Insurance: many insurers limit coverage to patients who meet the BMI/comorbidity criteria and may require documentation of prior weight‑loss attempts. Out‑of‑pocket costs can be high. Off‑label prescriptions via private pay or telehealth exist but can be expensive and vary by provider. Next practical steps Calculate your BMI (or tell me your height and current weight and I can calculate it). Bring BMI, a list of any weight‑related conditions, prior weight‑loss attempts, and medications to your primary care provider or an obesity medicine/endocrine specialist. If you want a telehealth option, services that evaluate and can prescribe after a visit include Hims & Hers, Ro (Roman), and PlushCare — they’ll assess eligibility and discuss costs. For specialist care, search the Obesity Medicine Association provider directory for local specialists. Ask about risks, monitoring (labs, thyroid/pancreatic symptoms), and an individualized plan including lifestyle support. If you want, tell me your height and current weight and I’ll calculate your BMI and say whether you’d meet the typical thresholds.

Mentioned in position 4 of 4

Short answer: before you pay, confirm the provider is legitimately licensed and experienced to prescribe Wegovy (semaglutide 2.4 mg), offers appropriate baseline testing and follow-up, is transparent about total cost and pharmacy/shipping, and has safety & emergency procedures in place. Checklist — what to verify before you pay Prescriber credentials and licensing: a board-certified MD/DO or NP/PA licensed in your state; bonus if they have obesity-medicine or endocrinology experience (ABOM certification or similar). Explicit drug and dose: they must say they will prescribe Wegovy (brand semaglutide 2.4 mg) or specify the exact semaglutide product/dose, not just “GLP‑1” generically. Initial evaluation and baseline testing: plan to review medical history, perform a telehealth exam, and order baseline labs (A1c, CMP/LFTs, TSH as indicated, pregnancy test for people who can become pregnant, lipids). Titration and follow-up schedule: clear titration plan per Wegovy labeling and regular follow-up visits (typically every few weeks during dose changes and at least monthly initially). Ongoing monitoring and access: readiness to adjust therapy, manage side effects (nausea, pancreatitis risk), and arrange in-person care or urgent referral if needed. Prior authorization and pharmacy handling: whether they submit prior auths and which pharmacy they'll use (specialty pharmacy vs. retail). Ask if they deliver/ship and how refrigerated handling is assured. Cost transparency: total monthly cost (drug + visit fees + labs + shipping + supplies), refund/cancellation policy, and whether they accept your insurance or help with manufacturer savings/copay cards. Multidisciplinary support: availability of dietary counseling, behavioral support, or a care team rather than a single rushed visit. Privacy and legal: HIPAA-compliant telehealth platform and clear consent/medical record access. Patient reviews and outcomes: third-party reviews and complaint history (Better Business Bureau, Trustpilot, Google reviews). Red flags (walk away or ask a lot of questions) No baseline labs or follow-up plan. One 10–15 minute visit and immediate prescription without medication counseling. Pressure to buy medication only from their in-house pharmacy with no alternatives. Vague cost or hidden recurring fees. Promises of unrealistic rapid weight loss or “miracle” results. No licensed prescriber listed or prescriber not licensed in your state. Questions to ask them before paying “Are you able to prescribe Wegovy (semaglutide 2.4 mg) specifically?” “Who will be my prescriber (name, credentials, state licensure) and are they board certified?” “What baseline tests do you order and who coordinates them?” “What is the planned titration and follow-up schedule?” “Do you help with prior authorization, copay cards, or specialty pharmacy issues?” “What is the total monthly out-of-pocket cost (drug + visits + labs + shipping)?” “What are your policies for missed meds, side effects, and refunds?” Telehealth providers and services commonly used for Wegovy/GLP‑1 care (Verify each one explicitly offers Wegovy before paying) Hims & Hers (Hers): consumer-focused, structured weight-loss programs with telehealth visits and follow-up; easy platform and patient support tools. PlushCare: established telemedicine provider that offers chronic-care management and weight-loss med prescriptions through primary-care clinicians. Ro (Roman) / Rory: known for telehealth treatment programs and follow-up; check whether they will prescribe brand Wegovy specifically. One Medical (now part of Amazon Care ecosystem in places): primary-care–based model that can coordinate labs and in-person care, good for continuity. Major telemedicine marketplaces (Teladoc, Amwell, MDLIVE): these can connect you to board-certified physicians and sometimes to endocrinologists/obesity specialists. Local obesity-medicine or endocrinology practices offering telehealth: often the best for complex history — find ABOM-certified clinicians via the Obesity Medicine Association (obesitymedicine.org) or your local health system. How to handle cost/insurance Wegovy is expensive; many providers will seek prior authorization. Ask them to submit it and to help apply manufacturer savings programs (Novo Nordisk copay cards). If insurance denies, ask about alternatives (tirzepatide products or off‑label lower-dose semaglutide) and exact out-of-pocket pricing. Compare total cost from multiple providers (visit fees + medication + shipping + labs) before committing. Final tip Document everything (prescriber name/license, visit notes, lab orders, prior-authorizations) and only pay after confirming the provider will do baseline testing and a clear follow-up/titration plan. If you want, tell me your state and whether you prefer a primary-care approach vs. an obesity specialist and I can suggest specific clinics available near you.

Mentioned in position 9 of 9

Short answer: You need a clinician to evaluate you and write a prescription. You can do that entirely online through telehealth or an obesity/weight-management clinic that offers tirzepatide (Zepbound). Below are practical steps, safety checks, and specific services to consider. 1) Confirm you’re likely eligible Zepbound (tirzepatide) is prescription-only for chronic weight management; typical eligibility has been BMI ≥30 kg/m² or ≥27 with at least one weight‑related condition (check with the clinician). Important contraindications/precautions to mention to any prescriber: personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy or planning pregnancy, history of pancreatitis, and concurrent insulin or sulfonylurea use (risk of hypoglycemia). A clinician will review these. 2) Gather basic info to speed the visit Current weight and height (to calculate BMI), medical history, medication list, recent labs if available (A1c if diabetic, kidney/liver tests if you have relevant conditions), and pregnancy test if applicable. Note prior weight-loss meds you’ve tried and reasons you stopped. 3) Choose a reputable telehealth or specialist service PlushCare — primary care telehealth that can evaluate and prescribe weight-loss meds; good for routine primary-care follow-up and prescriptions. Ro (Roman) — consumer telehealth known for offering weight-loss medication programs; straightforward online process. Hims & Hers — offers telehealth weight-management services including GLP-1/TZD options to qualified patients. One Medical — membership primary care with virtual visits and longer appointments; good if you want integrated care and follow-up. Zocdoc or the Obesity Medicine Association provider finder — use these to find local endocrinologists or board-certified obesity medicine physicians who do telehealth if you prefer a specialist. Note: availability of Zepbound specifically (some clinics may prescribe other tirzepatide/GLP-1-brand medications) varies by provider and stock. Ask each service whether they currently prescribe Zepbound vs. other tirzepatide/GLP-1 products. 4) The telehealth visit Expect a medical history review, discussion of goals/risks, and possible baseline labs. The clinician will decide whether to prescribe and will outline dosing/titration and monitoring. If you take insulin or sulfonylureas, your clinician should adjust doses to avoid hypoglycemia. 5) Getting the medication and paying for it The clinician can e-prescribe to your pharmacy or to a specialty pharmacy/home-delivery service. Coverage is highly variable. Check with your insurer about prior authorization rules for Zepbound; many plans require it for weight-loss drugs. Manufacturer co-pay savings or patient-assistance programs may be available — ask the prescribing clinic to help with prior auth and savings programs. GoodRx can show cash prices and coupons. 6) Safety and follow-up Plan for follow-up visits to check tolerability, dose adjustments, and side effects (nausea, GI upset, possible gallbladder issues, rare pancreatitis). Report any neck mass or persistent throat symptoms because of the thyroid warning. Do not buy prescription meds from unverified online pharmacies or import drugs without a prescription — risk of counterfeit or unsafe products. If you want, I can: Look up which of the named telehealth services currently lists Zepbound on their site (I can’t access the web right now, but I can give typical contact pages and scripts), or Draft a short message/template you can send when you book an appointment asking whether they prescribe Zepbound and what records they need. Which of those would you like next?

Mentioned in position 6 of 7

Short answer Many people lose noticeable weight within weeks and substantial weight over months, but speed and amount vary a lot by drug, dose, and person. Semaglutide (Wegovy) and tirzepatide (Zepbound/Mounjaro) produce the largest average losses in trials; liraglutide (Saxenda) less so. Weight is often regained if the medicine is stopped unless you build lasting lifestyle and behavioral changes, so long‑term treatment is commonly needed to sustain maximum benefit. What to expect (typical clinical-trial results and timelines) First 1–3 months: appetite drops, many people lose a few kilograms (a few lbs/wk can occur early). Dose escalation schedules also slow early speed. 3–6 months: most of the early weight loss occurs in this window. Typical ranges by drug (trial averages): Tirzepatide (Zepbound for weight loss; Mounjaro for diabetes): often the largest losses—many trials show mean losses of ~15–20% body weight at ~9–12 months on the higher doses. Semaglutide 2.4 mg (Wegovy): roughly 10–15% mean weight loss at ~12–18 months in STEP trials (about 15% at 68 weeks). Liraglutide 3.0 mg (Saxenda): smaller effect, roughly 5–10% at ~1 year in trials. 6–12 months: the rate slows and weight often plateaus. Further small losses are possible but slower. If you stop the drug: many people regain a large portion of the lost weight within months to a year unless other strategies are firmly in place. Concrete example If you weigh 100 kg (220 lb): a 10% loss = 10 kg (22 lb); on Wegovy many people average ~10–15 kg (22–33 lb) after about a year; on higher-dose tirzepatide some people average more (15–20+ kg), while on Saxenda the average is lower (~5–10 kg). Is it sustainable? Medication + behavior change is the best path to lasting weight loss. GLP-1s change appetite and food reward, which helps create the calorie deficit—but unless the underlying habits, food environment, activity, and coping strategies change, stopping medication usually leads to regain. Many clinicians therefore treat obesity as a chronic condition: ongoing medication may be recommended long-term for maintenance, similar to how we treat hypertension or diabetes. Risks, practical issues, and things to discuss with your clinician Side effects: nausea, vomiting, diarrhea, constipation, gallbladder issues, and rare but serious risks (pancreatitis, thyroid C‑cell tumors in animals). Not appropriate if pregnant or trying to conceive. Cost and access: insurance coverage varies (Wegovy/Zepbound may be covered inconsistently); some drugs are costly if uninsured. Need for medical supervision: dose escalation, safety checks, and attention to vitamins/nutrition and other meds are important. Recommended brands and services (and why) Wegovy (semaglutide 2.4 mg) — FDA‑approved specifically for chronic weight management; strong trial evidence (STEP) for ~10–15% average loss. Zepbound (tirzepatide) — newer FDA‑approved option for weight loss with very strong results in trials (often greater average percent loss than semaglutide). If not available, Mounjaro (tirzepatide) is used for diabetes and sometimes prescribed off‑label for weight loss under supervision. Saxenda (liraglutide) — older GLP‑1 option with more modest weight loss; may be an option if others aren’t suitable. Telemedicine weight‑management services (examples): Ro (offers supervised GLP‑1 programs and remote follow‑up), PlushCare (telehealth primary care + weight management), and local obesity or bariatric clinics for comprehensive in‑person care. These services can make access and monitoring easier but check licensure, protocols, and costs. For specialist care: find an obesity medicine physician through the Obesity Medicine Association’s "Find a Specialist" tool or seek a multidisciplinary bariatric/metabolic clinic (e.g., large academic centers like Cleveland Clinic Bariatric & Metabolic Institute) if you want coordinated medical, nutrition, and behavioral support. Practical tips to improve outcome and sustainability Combine medication with structured nutrition counseling (RD), behavioral therapy or coaching, and an exercise plan. Expect dose escalation: most schedules ramp slowly to reduce GI side effects. Track progress and side effects, and plan for long‑term maintenance (including the possibility of continuing medication). Discuss birth control/planning if applicable and avoid pregnancy while taking GLP‑1s. Next steps Talk with your primary care doctor or an obesity medicine specialist to see which drug (if any) fits your health profile, insurance, and goals. If you want names of local specialists or telemedicine programs that serve your state, tell me your state (or ZIP) and I can list options.

Mentioned in position 4 of 4